Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refractory Prostate Cancer
Clinical Cancer Research, 08/04/09
Fontana A et al. – Metronomic CTX plus CXB and DEX showed favorable toxicity and activity profile in patients. VE–C gene expression and VEGF levels represent potentially useful pharmacodynamic markers for the clinical response.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Is statin use associated with prostate cancer aggressiveness
BJU International, 11/09/09
Timetable of effects of testosterone administration to hypogonadal men on variables of sex and mood
The Aging Male, 11/13/09
What comes after docetaxel
Der Urologe, 11/18/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Is statin use associated with prostate cancer aggressiveness
BJU International, 11/09/09
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
What comes after docetaxel
Der Urologe, 11/18/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Is statin use associated with prostate cancer aggressiveness
BJU International, 11/09/09
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
What comes after docetaxel
Der Urologe, 11/18/09
Article Search
Sponsor


See Latest Articles


